CUAMC
China Universal Asset Management Company’s Enliven Therapeutics ELVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $198K | Buy |
9,855
+55
| +0.6% | +$1.1K | 0.02% | 313 |
|
|
2025
Q1 | $193K | Sell |
9,800
-560
| -5% | -$11K | 0.02% | 315 |
|
|
2024
Q4 | $233K | Buy |
10,360
+1,275
| +14% | +$28.7K | 0.02% | 316 |
|
|
2024
Q3 | $232K | Buy |
9,085
+3,559
| +64% | +$90.9K | 0.03% | 288 |
|
|
2024
Q2 | $129K | Sell |
5,526
-2,426
| -31% | -$56.7K | 0.02% | 282 |
|
|
2024
Q1 | $140K | Buy |
7,952
+3,189
| +67% | +$56.1K | 0.02% | 336 |
|
|
2023
Q4 | $65.9K | Buy |
+4,763
| New | +$65.9K | 0.01% | 336 |
|